Bottom line
CHNA vs SHSSX: the short answer
CHNA (Loncar China BioPharma ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both etfs.
Updated Nov 19, 2026
CHNA vs SHSSX side by side
| CHNA | SHSSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Grayscale | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | — | 0.86% |
| Annual cost per $10k | — | $86 |
| 10-yr cost on $10k (prospectus) | — | $1,061 |
| Max front load | None | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +16.3% |
| 5-yr return (annualized) | — | +5.9% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | — | $5.9B |
| Number of holdings | — | 155 |
| Portfolio turnover | — | 49% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
CHNA and SHSSX share none of their top holdings.
CHNA top 10
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between CHNA and SHSSX?
CHNA (Loncar China BioPharma ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both etfs.
Should I own both CHNA and SHSSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.